Learning tasks are implemented via mappings of the sampled data set, including both the classical and the quantum framework. Biomedical data characterizing complex diseases such as cancer typically require an algorithmic support for clinical decisions, especially for early stage tumors that typify breast cancer patients, which are still controllable in a therapeutic and surgical way. Our case study consists of the prediction during the pre-operative stage of lymph node metastasis in breast cancer patients resulting in a negative diagnosis after clinical and radiological exams. The classifier adopted to establish a baseline is characterized by the result invariance for the order permutation of the input features, and it exploits stratifications in the training procedure. The quantum one mimics support vector machine mapping in a high-dimensional feature space, yielded by encoding into qubits, while being characterized by complexity. Feature selection is exploited to study the performances associated with a low number of features, thus implemented in a feasible time. Wide variations in sensitivity and specificity are observed in the selected optimal classifiers during cross-validations for both classification system types, with an easier detection of negative or positive cases depending on the choice between the two training schemes. Clinical practice is still far from being reached, even if the flexible structure of quantum-inspired classifier circuits guarantees further developments to rule interactions among features: this preliminary study is solely intended to provide an overview of the particular tree tensor network scheme in a simplified version adopting just product states, as well as to introduce typical machine learning procedures consisting of feature selection and classifier performance evaluation.
Learning tasks are implemented via mappings of the sampled data set, including both the classical and the quantum framework. Biomedical data characterizing complex diseases such as cancer typically require an algorithmic support for clinical decisions, especially for early stage tumors that typify breast cancer patients, which are still controllable in a therapeutic and surgical way. Our case study consists of the prediction during the pre-operative stage of lymph node metastasis in breast cancer patients resulting in a negative diagnosis after clinical and radiological exams. The classifier adopted to establish a baseline is characterized by the result invariance for the order permutation of the input features, and it exploits stratifications in the training procedure. The quantum one mimics support vector machine mapping in a high-dimensional feature space, yielded by encoding into qubits, while being characterized by complexity. Feature selection is exploited to study the performances associated with a low number of features, thus implemented in a feasible time. Wide variations in sensitivity and specificity are observed in the selected optimal classifiers during cross-validations for both classification system types, with an easier detection of negative or positive cases depending on the choice between the two training schemes. Clinical practice is still far from being reached, even if the flexible structure of quantum-inspired classifier circuits guarantees further developments to rule interactions among features: this preliminary study is solely intended to provide an overview of the particular tree tensor network scheme in a simplified version adopting just product states, as well as to introduce typical machine learning procedures consisting of feature selection and classifier performance evaluation.
In this study, the performance of classical and quantum machine learning models was compared using the Breast Cancer dataset, which consists of diagnostic data aimed at classifying breast tumor types. Breast cancer, being one of the most common and life-threatening cancers in women, requires accurate diagnostic tools for early detection and effective treatment. The primary objective of this study is to evaluate the accuracy of quantum-assisted models through quantum feature selection methods. Initially, classical machine learning algorithms such as Support Vector Machines (SVM), Decision Trees, Random Forests, and Logistic Regression were applied to the dataset for baseline analysis. Subsequently, a quantum feature map was constructed using the Cirq library, enabling feature transformation based on this map. The classification was performed using the SVM model with the quantum-transformed features. The Logistic Regression and SVM models demonstrated the highest performance among classical machine learning models, achieving an accuracy rate of 96.49%, followed by Random Forest at 94.74% and Decision Tree at 92.11%. In the context of quantum feature transformation, the model utilizing the top five selected features achieved an accuracy rate of 94.74%, in contrast to 98.25% for the model trained with all features. These findings underscore the potential of quantum feature maps in enhancing model performance compared to classical techniques. The results suggest that quantum computing may offer significant advantages when integrated into machine learning frameworks, particularly in domains such as medical diagnostics, where high accuracy is crucial.
Patients at an early stage, which can help with prompt diagnosis and treatment of the condition. This study utilizes a retrospective cohort design, where health records of patients with and without breast cancer were obtained from a large healthcare database. The data were pre- processed to remove missing values, and feature engineering techniques were used to extract relevant features. The predictive models were created, QSVM, Classical ML models (SVM, Random Forest. The goal of this research was to develop a predictive model for detecting breast cancer early in patients. The models were able to achieve high accuracy, precision, and recall rates, indicating their effectiveness in predicting the likelihood of breast cancer in patients. The model can be used to pinpoint people at high risk for illness development who need additional diagnostic tests or early intervention. The creation of a Breast cancer predictive model using health information is the sole focus of this work. The model can be incorporated into clinical decision support systems. In order to examine the viability of adopting the model in clinical practice, more research is required to validate the model in a variety of demographics and situations.
Early and accurate diagnosis of breast cancer plays a critical role in improving patient survival rates and reducing treatment costs. Classical machine learning algorithms such as Logistic Regression and Support Vector Machines (SVM) have demonstrated strong performance in medical diagnosis tasks; however, their scalability and representational limits motivate the exploration of emerging paradigms. Quantum Machine Learning (QML), particularly Variational Quantum Classifiers (VQC), has recently gained attention due to its potential to model complex decision boundaries using quantum circuits. This paper presents a comparative analysis between a Variational Quantum Classifier and classical machine learning models for binary breast cancer classification. The study employs dimensionality-reduced clinical data and evaluates model performance using accuracy, confusion matrices, decision boundary visualization, Principal Component Analysis (PCA), and Receiver Operating Characteristic (ROC) curves. Experimental results indicate that the VQC achieves competitive performance with classical approaches, demonstrating its feasibility for small-scale medical datasets and highlighting the promise of quantum-enhanced learning in healthcare applications.
Breast cancer is a major health concern, and early detection can make a great difference in treatment and survival rates for breast cancer patients. Machine learning methods have noticeably improved prediction accuracy on high-dimensional medical datasets and have become widely used tools in medical diagnostics. The transition to a quantum computational framework has opened new directions in machine learning research. By using qubits instead of classical bits, quantum models may provide new ways to represent and process complex medical data. In medical diagnostics, this has led to a growing interest in whether quantum approaches can improve classification performance more effectively than classical methods. The purpose of this paper is to compare classical and quantum machine learning models on the task of breast cancer classification and to determine whether quantum models can achieve higher accuracy and faster prediction on a selected dataset. Alongside the main simulator-based experiment, a smaller experiment was performed on a real IBM quantum computer to demonstrate the practical execution of the same task under current hardware constraints. In the practical part of the study, the Wisconsin Diagnostic Breast Cancer (WDBC) dataset was used. This dataset consists of 569 samples with 30 numerical features extracted from digitized fine needle aspirate images and provides a reliable basis for evaluating model performance. A comparative analysis was conducted between classical and quantum machine learning models, including a support vector machine (SVM), an artificial neural network (ANN), a quantum support vector machine (QSVM), and a hybrid quantum-classical neural network (QNN). In the simulator-based experiment, both SVM and ANN achieved an accuracy of 0.956 with an F1-score of 0.965 on the test set, while QSVM reached an accuracy of 0.807 with an F1-score of 0.866 and the Hybrid QNN achieved 0.623 accuracy with an F1-score of 0.677. These quantum and hybrid models also required substantially longer training times than the classical baselines. A small hardware experiment on an IBM quantum device further illustrates both the practical feasibility and the current limitations of executing this classification task on noisy intermediate-scale quantum hardware.
Breast cancer continues to be among the most common causes of cancer death globally, with early and precise diagnosis playing a pivotal role in enhancing patient survival. Traditional machine learning (ML) techniques have shown great promise in the field of medical imaging and diagnosis; however, the emergence of quantum machine learning (QML) offers new avenues for the improvement of pattern discovery and diagnostic accuracy in high-dimensional medical data. This work describes a thorough benchmark comparison of quantum and classical machine learning methods for breast cancer diagnosis over the Wisconsin Diagnostic Breast Cancer data and mammographic image data. We compare variational quantum classifiers (VQC), quantum kernel methods (QKM), quantum convolutional neural networks (QCNNs), and hybrid quantum-classical neural structures with traditional classical baselines like support vector machines (SVM) and convolutional neural networks (CNN). QKM techniques perform better in high-dimensional feature spaces and better generalize on external validation sets. This implementation framework describes in depth how to develop, train, and deploy QML models in the clinical workflow, including optimization approaches, code structures, and deployment issues. The work demonstrates that it is possible to streamline breast cancer screening and diagnosis using QML with more accurate and more efficient solutions, which would lead to a huge impact on patient outcomes.
This chapter investigates a Hybrid Quantum-Classical Machine Learning framework for medical diagnosis. Integrating quantum computing with classical deep learning, the framework addresses computational limitations in processing high-dimensional biomedical data. Four clinical use cases are evaluated: histopathology-based cancer detection using Variational Quantum Circuits, MRI-based Alzheimer's classification using Quantum Convolutional Neural Networks, diabetes prediction using Quantum Support Vector Machines, and drug-target interaction prediction using Quantum Graph Neural Networks. Results demonstrate diagnostic performance competitive with classical baselines, with quantum advantage most evident in high-dimensional kernel estimation and quantum chemistry-informed prediction. Data encoding strategies, hardware noise mitigation, privacy compliance, and a phased clinical deployment roadmap are discussed.